Method for detecting residual monomers in PHA polymer and application thereof

Through the detection method of gas chromatography-mass spectrometry, the problem of detection of residual monomers in PHA polymers was solved, and high sensitivity quantitative analysis of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid was achieved, ensuring the biocompatibility of the material and safety, suitable for medical beauty.

CN119086776APending Publication Date: 2024-12-06BEIJING MEIYAN SPACE BIOMEDICINE CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411370719.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-29
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art is difficult to accurately detect the residual 3-hydroxybutyric acid and 3-hydroxyhexanoic acid monomers in PHA polymers, which affects the biocompatibility and safety of the material, and especially in medical and cosmetic applications, its content needs to be strictly controlled.

Method used

The quantitative analysis of residual monomers was achieved through peak area calculation using a gas chromatography-mass spectrometry combination detection method, using a strong polar stationary chromatography column and an electron bombardment ion source, combined with specific gas phase and mass spectrometry conditions.

Benefits of technology

It realizes high sensitivity and good repeatability detection of residual monomers in PHA polymers, simple operation and high accuracy, and can effectively ensure the finished product quality of the material.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005067494550000061
    Figure BDA0005067494550000061
  • Figure BDA0005067494550000062
    Figure BDA0005067494550000062
  • Figure BDA0005067494550000071
    Figure BDA0005067494550000071
Patent Text Reader

Abstract

The invention provides a method for detecting residual monomers in a PHA polymer and application of the method. According to the method, a gas chromatography-mass spectrometry method is specifically adopted, a reference solution is taken as a reference, and the content of residual monomers in a test sample is calculated according to an external standard method and a peak area. The method has the advantages of good linearity, good repeatability, high accuracy, high sensitivity and good durability. The method does not need derivatization pretreatment on a sample, is simple and convenient to operate and short in time consumption, and can effectively guarantee the quality of a PHA polymer finished product.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical detection technology, and in particular to a detection method for residual monomers in a PHA polymer and an application thereof. Background Art

[0002] As people age, the muscles and collagen tissues in the human body will experience varying degrees of functional degeneration. Based on this, people have developed various fillers, such as hyaluronic acid, but its duration as a filler is short and requires frequent injections. In order to achieve long-term filling effects, people have tried to use non-biodegradable materials such as polyvinyl alcohol (PVA) microspheres as fillers. Although the maintenance effect of such fillers has been significantly increased, these materials will release harmful substances if they remain in the body for too long, triggering a series of side effects and endangering human health.

[0003] Polyhydroxyalkanoates (PHA) is a new type of biodegradable polymer material. PHA is mainly divided into the first generation PHB, the second generation PHBV, the third generation PHBHHx, the fourth generation P34HB, and the fifth generation PHBVHHx. Among them, PHB is an oligomer composed only of 3-hydroxybutyric acid (3HB) as a monomer, PHBV is a copolymer of 3-hydroxybutyric acid (3HB) and 3-hydroxyvaleric acid (3HV), PHBHHx (i.e. P3HB-co-3HHx) is a copolymer of 3-hydroxybutyric acid (3HB) and 3-hydroxyhexanoic acid (3HHx), and is also the first short-chain and medium-chain PHA copolymer discovered and studied. Compared with PHB, it has good flexibility, and the material properties change with the content of the copolymer chain segments. P34HB (i.e. P3HB-co-4HB) is a copolymer of 3-hydroxybutyric acid (3HB) and 4-hydroxybutyric acid (4HB), PHBVHHx is a copolymer of 3-hydroxybutyric acid (3HB), 3-hydroxyhexanoic acid (3HHx) and 3-hydroxyvaleric acid (3HV), in addition, there are polyhydroxyhexanoate, i.e. PHHx, and polyhydroxyoctanoate, PHO, etc. PHA polymer has good biocompatibility. Cells can grow well on this scaffold, and the scaffold can be degraded into CO2 and H2O. PHA is one of the most ideal biomedical materials at present. The development of PHA skin fillers has important industrial value and broad application prospects.

[0004] Microbial fermentation is the main method for industrial production of PHA. PHA polymers are prone to residual monomer molecules. PHA polymers used for medical beauty need to strictly control the content of residual monomers according to industry standards. Developing a method that can accurately detect residual monomers in polymers has important industrial value. Summary of the invention

[0005] An object of one aspect of the present invention is to provide a method for detecting residual monomers in a PHA polymer, wherein the method adopts a gas chromatography-mass spectrometry detection method, wherein the gas chromatography column is a highly polar stationary phase chromatography column; the residual monomers include 3-hydroxybutyric acid and / or 3-hydroxyhexanoic acid.

[0006] In a preferred embodiment of the present invention, the PHA polymer is a natural or non-natural polyhydroxyalkanoate, and the natural or non-natural polyhydroxyalkanoate includes PHB, PHBV, PHBHHx, P34HB, PHBVHHx, PHHx and PHO, etc.

[0007] In a preferred embodiment of the present invention, the PHA polymer is PHBHHx or PHB or PHHx.

[0008] In a preferred embodiment of the present invention, the gas chromatography conditions of the detection method meet at least one of the following conditions (1) to (7):

[0009] (1) The gas chromatography column is a nitroterephthalic acid-modified polyethylene glycol column, preferably Agilent DB-FFAP, more preferably Agilent DB-FFAP, 30m×0.25mm, 0.25μm;

[0010] (2) the carrier gas used is selected from nitrogen, argon, helium or carbon dioxide, preferably helium;

[0011] (3) The heating program is: initial temperature 50-70°C, heating to 210-230°C at a rate of 15-25°C / min, maintaining for 1-5 min, and then running at 210-230°C and maintaining for 5-15 min; preferably, the initial temperature is 60°C, heating to 220°C at a rate of 20°C / min, maintaining for 3 min, and then running at 220°C and maintaining for 10 min;

[0012] (4) The carrier gas flow rate is 0.8-1.2 ml / min, preferably 0.9-1.1 ml / min;

[0013] (5) The split ratio of the injection port is 8-12:1, preferably 10:1;

[0014] (6) The temperature of the injection port is 240-260°C, preferably 245-255°C;

[0015] (7) The injection volume is 0.5-2 μl, preferably 1 μl.

[0016] In a preferred embodiment of the present invention, the mass spectrometry conditions of the detection method meet at least one of the following conditions (1) to (6):

[0017] (1) The mass spectrometry ion source is an electron impact ion source (EI), a chemical ionization source (CI), a field ionization source / field dissociation ionization source (FI / FD), an electrospray ionization source (ESI), an atmospheric pressure chemical ionization source (APCI) or a matrix-assisted laser desorption ionization source (MALDI), preferably an electron impact ionization source (EI);

[0018] (2) The mass spectrometry ion source temperature is 220-240°C, preferably 230°C;

[0019] (3) The mass spectrometer quadrupole temperature is 140-160°C, preferably 150°C;

[0020] (4) The mass spectrometry scanning mode is selected ion monitoring (SIM), full scan (Full Scan) or multidimensional scanning (MRM), preferably selected ion monitoring (SIM);

[0021] (5) The mass spectrometry solvent is delayed for 3-5 minutes, preferably 4 minutes;

[0022] (6) The mass spectrometry ion pairs are as follows:

[0023] Compound Quantitative ion Qualifier ion 1 Qualifier ion 2 3-Hydroxybutyric Acid 71 60 89 3-Hydroxyhexanoic acid 103 71 74

[0024] In a preferred embodiment of the present invention, the detection method further comprises at least one of the following steps:

[0025] (1) Steps for solution preparation:

[0026] Test solution: Take an appropriate amount of PHA polymer, dissolve it in a solvent and quantitatively dilute it to make a solution of a certain concentration;

[0027] Reference solution: Take an appropriate amount of residual monomer compound standard, dissolve it with a solvent and quantitatively dilute it to prepare a solution of a certain concentration; preferably, the solvent is selected from at least one of dichloromethane, chloroform, methanol, ethanol, isopropanol, acetone, acetonitrile and ethyl acetate; more preferably, the solvent is dichloromethane;

[0028] (2) Steps for content calculation: Calculate the residual monomer content in the test sample using the peak area according to the external standard method.

[0029] In a preferred embodiment of the present invention, the detection method specifically comprises:

[0030] (1) Solution preparation:

[0031] Test solution: Take an appropriate amount of PHA polymer, dissolve it in a solvent and quantitatively dilute it to make a solution of a certain concentration;

[0032] Reference solution: Take an appropriate amount of residual monomer compound standard, dissolve it in a solvent and quantitatively dilute it to prepare a solution of a certain concentration; (2) The test solution and the reference solution of step (1) are tested by gas chromatography-mass spectrometry, and the specific conditions are as follows:

[0033] ①Gas chromatography:

[0034] Chromatographic column: Polyethylene glycol column modified with nitroterephthalic acid

[0035] Carrier gas: Helium Heating program: Initial temperature 50-70℃, heat to 210-230℃ at a rate of 15-25℃ / min, maintain for 1-5min, then run at 210-230℃ for 5-15min

[0036] Flow rate: 0.8-1.2ml / min

[0037] Split ratio: 10:1

[0038] Inlet temperature: 240-260℃

[0039] Injection volume: 0.5-2μl

[0040] ②Mass spectrometry:

[0041] Ion source: EI source

[0042] Ion source temperature: 230°C

[0043] Quadrupole temperature: 150°C

[0044] Acquisition mode: Selected ion monitoring SIM

[0045] The ion pairs are shown in the table below:

[0046] Compound Quantitative ion Qualifier ion 1 Qualifier ion 2 3-Hydroxybutyric Acid 71 60 89 3-Hydroxyhexanoic acid 103 71 74

[0047] (3) Calculation of content:

[0048] The residual monomer content in the test sample was calculated by the peak area using the external standard method.

[0049] In a preferred embodiment of the present invention, the detection method specifically comprises:

[0050] (1) Solution preparation:

[0051] Test solution: Take an appropriate amount of PHA polymer, dissolve it in dichloromethane and quantitatively dilute it to make a solution containing about 5 mg per 1 ml.

[0052] Reference solution: Take appropriate amounts of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid, dissolve them in dichloromethane and quantitatively dilute them to make a mixed solution containing about 50 μg of each in 1 ml.

[0053] (2) Chromatographic conditions:

[0054] ①Gas chromatography:

[0055] Column: Agilent DB-FFAP, 30m×0.25mm, 0.25μm

[0056] Carrier gas: Helium Heating program: Initial temperature 60℃, increase to 220℃ at a rate of 20℃ / min, maintain for 3min, then maintain at 220℃ for 10min.

[0057] Flow rate: 0.9-1.1ml / min

[0058] Split ratio: 10:1

[0059] Inlet temperature: 245-255°C

[0060] Injection volume: 1 μl

[0061] ②Mass spectrometry:

[0062] Ion source: EI source,

[0063] Ion source temperature: 230°C,

[0064] Quadrupole temperature: 150°C

[0065] Acquisition mode: Selected ion monitoring SIM

[0066] Solvent delay: 4 minutes

[0067] The ion pairs are shown in the table below:

[0068] Compound Quantitative ion Qualifier ion 1 Qualifier ion 2 3-Hydroxybutyric Acid 71 60 89 3-Hydroxyhexanoic acid 103 71 74

[0069] (3) Calculation of content:

[0070] The residual monomer content in the test sample was calculated by the peak area using the external standard method.

[0071] Another object of the present invention is to provide an application of the detection method of the present invention in detecting residual monomers in a PHA polymer.

[0072] In a preferred embodiment of the present invention, the PHA polymer is used as a dermal filler for medical cosmetics.

[0073] Unless otherwise specified, when the present invention relates to the percentage between liquids, the percentage is volume / volume percentage; when the present invention relates to the percentage between liquids and solids, the percentage is volume / weight percentage (ml / g); when the present invention relates to the percentage between solids and liquids, the percentage is weight / volume percentage (g / ml); the rest are weight / weight percentages.

[0074] Compared with the prior art, the present invention has the following beneficial effects:

[0075] The present invention scientifically screens a detection method for residual monomers in PHA polymers, realizes highly sensitive detection of residual monomers in polymers, and the method has good repeatability, high accuracy and good durability.

[0076] The method of the present invention does not require derivatization of the sample, is simple and convenient to operate, and takes a short time, and can effectively ensure the quality of the finished PHA polymer product. BRIEF DESCRIPTION OF THE DRAWINGS

[0077] Figure 1 It is the chromatogram of 3-hydroxybutyric acid of Comparative Example 1;

[0078] Figure 2 is the chromatogram of 3-hydroxyhexanoic acid of Comparative Example 1;

[0079] Figure 3 It is the characteristic ion current diagram of 3-hydroxybutyric acid of Comparative Example 2;

[0080] Figure 4 It is the characteristic ion current diagram of 3-hydroxyhexanoic acid of Comparative Example 2;

[0081] Figure 5 It is the chromatogram of 3-hydroxybutyric acid of Comparative Example 3;

[0082] Figure 6 is the chromatogram of 3-hydroxyhexanoic acid of Comparative Example 3;

[0083] Figure 7 is the mass spectrum of 3-hydroxybutyric acid of Comparative Example 4;

[0084] Figure 8 This is the total ion current diagram of 3-hydroxybutyric acid in Comparative Example 4;

[0085] Fig. 9 is the mass spectrum of 3-hydroxyhexanoic acid of Comparative Example 4;

[0086] Fig.10 is the total ion current diagram of 3-hydroxyhexanoic acid of Comparative Example 4;

[0087] Fig.11 is the mass spectrum of 3-hydroxybutyric acid in Example 1;

[0088] Fig.12 is the total ion current diagram of 3-hydroxybutyric acid in Example 1;

[0089] Fig.13 is the mass spectrum of 3-hydroxyhexanoic acid of Example 1;

[0090] Fig.14 is the total ion current diagram of 3-hydroxyhexanoic acid in Example 1;

[0091] Fig.15 is a linear graph of 3-hydroxybutyric acid in Example 2;

[0092] Fig.16 This is the linear graph of 3-hydroxyhexanoic acid of Example 2. DETAILED DESCRIPTION

[0093] To make the purpose, technical solution and advantages of the present invention more clear, the embodiments of the present invention will be described in detail with reference to the accompanying drawings. It should be noted that the embodiments of the present invention and the features in the embodiments can be combined with each other arbitrarily without conflict.

[0094] Comparative Example 1 High Performance Liquid Chromatography-CAD Detection of Monomer Compounds

[0095] Chromatographic column: Agilent ZORBAX SB-C18, 4.6×250 mm, 5 μm

[0096] Mobile phase: Phase A is water, phase B is acetonitrile

[0097] The flow rate was 1.0 ml / min, the column temperature was 40 °C, and the injection volume was 20 μl.

[0098] The gradient elution program is shown in Table 1:

[0099] Table 1

[0100]

[0101] Detector: Electrospray detector (CAD), atomization temperature 35°C, atomization pressure 50-60 psi

[0102] Test solution: Take an appropriate amount of 3-hydroxybutyric acid, dissolve it in acetonitrile and dilute it to make a solution containing about 1 mg per 1 ml. Take an appropriate amount of 3-hydroxyhexanoic acid, dissolve it in acetonitrile and dilute it to make a solution containing about 1 mg per 1 ml.

[0103] The chromatographic results of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid are shown in Figure 1 , 2 The results showed that the peak shapes of the two compounds were poor and could not meet the requirements of quantitative detection.

[0104] Comparative Example 2 Detection of Monomer Compounds by High Performance Liquid Chromatography-Mass Spectrometry

[0105] ① HPLC conditions

[0106] Chromatographic column: Agilent Infinitylab Poroshell 120EC-C18 (3×100mm, 1.9μm)

[0107] Mobile phase: Phase A is 0.1% ammonia water, phase B is acetonitrile

[0108] The flow rate was 0.25 ml / min, the column temperature was 35 °C, and the injection volume was 10 μl.

[0109] The gradient elution program is shown in Table 2:

[0110] Table 2

[0111]

[0112]

[0113] Preparation of mixed solution: Take appropriate amount of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid, dissolve them in acetonitrile and quantitatively dilute to make a mixed solution containing about 500 ng of each per ml.

[0114] ②Mass spectrometry conditions

[0115] Detector: Triple quadrupole detector

[0116] Ion source: ESI source

[0117] Detection mode: negative ion mode

[0118] The air curtain pressure is 40 psi

[0119] Ionization voltage is 4500V

[0120] Temperature 550℃

[0121] The collision gas pressure was 6 psi

[0122] The spray air pressure is 40 psi

[0123] Auxiliary heating gas pressure is 40psi

[0124] The ion pairs are shown in Table 3:

[0125] Table 3

[0126] Compound Precursor ion / daughter ion CE(V) 3-Hydroxybutyric Acid 103.1 / 41.0(-) -31 3-Hydroxyhexanoic acid 131.1 / 59.1(-) -15

[0127] The chromatographic results of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid are shown in Figure 3 , 4 The results showed that the ion peaks of the two compounds could not be separated and could not meet the requirements of quantitative detection.

[0128] Comparative Example 3 Gas Chromatography-FID Detection of Monomer Compounds

[0129] Column: Agilent DB-WAX, 30m×0.53mm, 1μm

[0130] Carrier gas: Nitrogen

[0131] Heating program: 150℃ constant temperature

[0132] Flow rate: 3.0ml / min

[0133] Split ratio: 20:1

[0134] Inlet temperature: 250℃

[0135] Detector: Flame ionization detector (FID), 250°C

[0136] Injection volume: 1 μl

[0137] Test solution: Take an appropriate amount of 3-hydroxybutyric acid, dissolve it in dichloromethane and dilute it to make a solution containing about 1 mg per 1 ml. Take an appropriate amount of 3-hydroxyhexanoic acid, dissolve it in dichloromethane and dilute it to make a solution containing about 1 mg per 1 ml.

[0138] The chromatographic results of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid are shown in Figure 5 , 6 The results showed that the two compounds could not be separated and could not meet the requirements of quantitative detection.

[0139] Comparative Example 4 Gas chromatography-mass spectrometry detection of monomer compounds

[0140] ①Gas chromatography:

[0141] Chromatographic column: Agilent HP-5MS, 30m×0.25mm, 0.25μm

[0142] Carrier gas: Helium

[0143] Heating program: initial temperature 40℃, heating to 150℃ at a rate of 8℃ / min, maintaining for 2min, then heating to 270℃ at a rate of 6℃ / min, maintaining for 4min,

[0144] Flow rate: 1.0ml / min

[0145] Split ratio: 10:1

[0146] Inlet temperature: 270°C

[0147] Injection volume: 1 μl

[0148] ②Mass spectrometry:

[0149] Ion source: EI source,

[0150] Ion source temperature: 230°C,

[0151] Quadrupole temperature: 150°C

[0152] Mode: SCAN

[0153] Solvent delay: 2 minutes

[0154] The ion pairs are shown in Table 4:

[0155] Table 4

[0156] Compound Quantitative ion Qualifier ion 1 Qualifier ion 2 3-Hydroxybutyric Acid 71 60 89 3-Hydroxyhexanoic acid 103 71 74

[0157] Test solution: Take an appropriate amount of 3-hydroxybutyric acid, dissolve it in dichloromethane and dilute it to make a solution containing about 1 mg per 1 ml. Take an appropriate amount of 3-hydroxyhexanoic acid, dissolve it in dichloromethane and dilute it to make a solution containing about 1 mg per 1 ml.

[0158] The chromatographic results of 3-hydroxybutyric acid are shown in Figure 7-8 , the chromatographic results of 3-hydroxyhexanoic acid are shown in Figure 9-10 The results showed that the peak shapes of the two compounds were poor and could not meet the requirements of quantitative detection.

[0159] Example 1 Gas chromatography-mass spectrometry detection of monomeric compounds

[0160] ①Gas chromatography:

[0161] Column: Agilent DB-FFAP, 30m×0.25mm, 0.25μm

[0162] Carrier gas: Helium

[0163] Heating program: Initial temperature 60℃, heating to 220℃ at a rate of 20℃ / min, maintaining for 3min, then maintaining at 220℃ for 10min

[0164] Flow rate: 1.0ml / min

[0165] Split ratio: 10:1

[0166] Inlet temperature: 250℃

[0167] Injection volume: 1 μl

[0168] ②Mass spectrometry:

[0169] Ion source: EI source

[0170] Ion source temperature: 230°C

[0171] Quadrupole temperature: 150°C

[0172] Acquisition mode: Selected ion monitoring SIM

[0173] Solvent delay: 4 minutes

[0174] The ion pairs are shown in Table 5:

[0175] Table 5

[0176] Compound Quantitative ion Qualifier ion 1 Qualifier ion 2 3-Hydroxybutyric Acid 71 60 89 3-Hydroxyhexanoic acid 103 71 74

[0177] Test solution: Take an appropriate amount of 3-hydroxybutyric acid, dissolve it in dichloromethane and dilute it to make a solution containing about 1 mg per 1 ml. Take an appropriate amount of 3-hydroxyhexanoic acid, dissolve it in dichloromethane and dilute it to make a solution containing about 1 mg per 1 ml.

[0178] The chromatographic results of 3-hydroxybutyric acid are shown in Figure 11-12 , the chromatographic results of 3-hydroxyhexanoic acid are shown in Figure 13-14 The results showed that the peak shapes of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid were good and baseline separation could be achieved, meeting the requirements for quantitative detection.

[0179] Example 2 Linearity of the Monomer Compounds of the Present Invention Detected by Gas Chromatography-Mass Spectrometry

[0180] Take appropriate amount of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid, accurately weigh them, dissolve them in dichloromethane and quantitatively dilute them to make a mixed solution containing approximately 500 μg of each in each ml; accurately measure an appropriate amount of the mixed solution, dilute it with dichloromethane to make a series of linear test solutions containing approximately 5 μg, 25 μg, 50 μg, 75 μg, and 100 μg in each ml.

[0181] The chromatographic conditions are the same as those in Example 1. The linear results of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid are shown in Table 6 below, and the standard curves of the two are shown in Table 6. Fig.15 , 16 .

[0182] Table 6

[0183]

[0184] Example 3 Repeatability of the gas chromatography-mass spectrometry detection method of the present invention

[0185] Reference solution: Take appropriate amounts of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid, weigh accurately, dissolve in dichloromethane and quantitatively dilute to make a mixed solution containing approximately 50 μg of each per 1 ml.

[0186] Spiked test solution: Take about 50 mg of PHA (PHBHHx, molecular weight 50-150Kda, average 110Kda), accurately weigh, place in a 10 ml volumetric flask, dissolve and dilute to the scale with 10 ml of reference solution, shake well, and prepare 6 copies in parallel.

[0187] The chromatographic conditions were the same as in Example 1. The repeatability results are shown in Table 7 below.

[0188] Table 7

[0189]

[0190] Example 4 Accuracy of the gas chromatography-mass spectrometry detection method of the present invention

[0191] Reference solution: Take appropriate amounts of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid, weigh accurately, dissolve in dichloromethane and quantitatively dilute to make a mixed solution containing approximately 50 μg of each per 1 ml.

[0192] Reference substance stock solution: Take appropriate amounts of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid, weigh accurately, dissolve in dichloromethane and quantitatively dilute to prepare a mixed solution containing approximately 500 μg of each per 1 ml.

[0193] 50% spiked test solution: Take about 50 mg of PHA (PHBHHx, molecular weight 50-150Kda, average 110Kda), accurately weigh, place in a 10 ml volumetric flask, add 0.5 ml of reference stock solution, dissolve and dilute to the scale with dichloromethane, shake well, and prepare 3 copies in parallel.

[0194] 100% spiked test solution: Take about 50 mg of PHA (same as above), accurately weigh, place in a 10 ml volumetric flask, add 1.0 ml of reference stock solution, dissolve and dilute to the scale with dichloromethane, shake well, and prepare 3 copies in parallel.

[0195] 150% spiked test solution: Take about 50 mg of PHA (same as above), accurately weigh, place in a 10 ml volumetric flask, add 1.5 ml of reference stock solution, dissolve and dilute to the scale with dichloromethane, shake well, and prepare 3 copies in parallel.

[0196] The chromatographic conditions were the same as in Example 1. The accuracy results are shown in Table 8 below.

[0197] Table 8

[0198]

[0199]

[0200] Example 5 Sensitivity of the gas chromatography-mass spectrometry detection method of the present invention

[0201] Reference solution: Take appropriate amount of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid, weigh accurately, dissolve in dichloromethane and quantitatively dilute to prepare a mixed solution containing about 50 μg of each per 1 ml. Accurately measure an appropriate amount of reference solution and dilute 10 times with dichloromethane as the quantitative limit solution; accurately measure an appropriate amount of reference solution and dilute 20 times with dichloromethane as the detection limit solution; the chromatographic conditions are the same as in Example 1. The sensitivity results are shown in Table 9 below.

[0202] Table 9

[0203] Compound Limit of quantification (ng) S / N Detection limit (ng) S / N 3-Hydroxybutyric Acid 4.61 35 2.30 14 3-Hydroxyhexanoic acid 6.15 52 3.08 18

[0204] Example 6 Durability of the gas chromatography-mass spectrometry detection method of the present invention

[0205] Reference solution: Take appropriate amounts of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid, weigh accurately, dissolve in dichloromethane and quantitatively dilute to make a mixed solution containing approximately 50 μg of each per 1 ml.

[0206] Spiked test solution: Take about 50 mg of PHA (PHBHHx, molecular weight 50-150Kda, average 110Kda), accurately weigh, place in a 10 ml volumetric flask, dissolve and dilute to the scale with 10 ml of reference solution, and shake well.

[0207] The chromatographic conditions were the same as in Example 1. The durability results are shown in Table 10 below.

[0208] Table 10

[0209]

[0210] The results show that after slightly adjusting some of the chromatographic conditions of Example 1 of the present invention, the detected amounts of the two monomer compounds in the spiked test solution remain constant, and the method of the present invention has good durability.

[0211] Although the embodiments disclosed in the present invention are as above, the contents described are only embodiments adopted to facilitate understanding of the present invention and are not intended to limit the present invention. Any technician in the field to which the present invention belongs can make any modifications and changes in the form and details of the implementation without departing from the spirit and scope disclosed in the present invention, but the patent protection scope of the present invention shall still be subject to the scope defined in the attached claims.

Claims

1. A method for detecting residual monomers in a PHA polymer, characterized in that: A gas chromatography-mass spectrometry detection method is adopted, wherein the gas chromatography column is a strong polar stationary phase chromatography column; the residual monomers include 3-hydroxybutyric acid and / or 3-hydroxyhexanoic acid.

2. The detection method according to claim 1, characterized in that: The PHA polymer is a natural or non-natural polyhydroxyalkanoate, preferably PHB, PHBV, PHBHHx, P34HB, PHBVHHx, PHHx or PHO, more preferably PHBHHx, PHB or PHHx.

3. The detection method according to claim 1 or 2, characterized in that: The gas chromatography conditions satisfy at least one of the following conditions (1) to (7): (1) The gas chromatography column is a nitroterephthalic acid-modified polyethylene glycol column, preferably Agilent DB-FFAP, more preferably Agilent DB-FFAP, 30m×0.25mm, 0.25μm; (2) the carrier gas used is selected from nitrogen, argon, helium or carbon dioxide, preferably helium; (3) The heating program is: initial temperature 50-70°C, heating to 210-230°C at a rate of 15-25°C / min, maintaining for 1-5 min, and then running at 210-230°C and maintaining for 5-15 min; preferably, the initial temperature is 60°C, heating to 220°C at a rate of 20°C / min, maintaining for 3 min, and then running at 220°C and maintaining for 10 min; (4) The carrier gas flow rate is 0.8-1.2 ml / min, preferably 0.9-1.1 ml / min; (5) The split ratio of the injection port is 8-12:1, preferably 10:1; (6) The temperature of the injection port is 240-260°C, preferably 245-255°C; (7) The injection volume is 0.5-2 μl, preferably 1 μl.

4. The detection method according to any one of claims 1 to 3, characterized in that: The mass spectrometry conditions satisfy at least one of the following conditions (1) to (6): (1) The mass spectrometry ion source is an electron impact ion source (EI), a chemical ionization source (CI), a field ionization source / field dissociation ionization source (FI / FD), an electrospray ionization source (ESI), an atmospheric pressure chemical ionization source (APCI) or a matrix-assisted laser desorption ionization source (MALDI), preferably an electron impact ionization source (EI); (2) The mass spectrometry ion source temperature is 220-240°C, preferably 230°C; (3) The mass spectrometer quadrupole temperature is 140-160°C, preferably 150°C; (4) The mass spectrometry scanning mode is selected ion monitoring (SIM), full scan (Full Scan) or multidimensional scanning (MRM), preferably selected ion monitoring (SIM); (5) The mass spectrometry solvent is delayed for 3-5 minutes, preferably 4 minutes; (6) The mass spectrometry ion pairs are shown in the following table:

5. The detection method according to any one of claims 1 to 4, characterized in that: The detection method further comprises at least one of the following steps: (1) Steps for solution preparation: Test solution: Take an appropriate amount of PHA polymer, dissolve it in a solvent and quantitatively dilute it to make a solution of a certain concentration; Reference solution: Take an appropriate amount of residual monomer compound standard, dissolve it in a solvent and quantitatively dilute it to make a solution of a certain concentration; Preferably, the solvent is selected from at least one of dichloromethane, chloroform, methanol, ethanol, isopropanol, acetone, acetonitrile and ethyl acetate; more preferably, the solvent is dichloromethane; (2) Steps for content calculation: Calculate the residual monomer content in the test sample using the peak area according to the external standard method.

6. The detection method according to any one of claims 1 to 5, characterized in that: The method specifically comprises: (1) Solution preparation: Test solution: Take an appropriate amount of PHA polymer, dissolve it in a solvent and quantitatively dilute it to make a solution of a certain concentration; Reference solution: Take an appropriate amount of residual monomer compound standard, dissolve it in a solvent and quantitatively dilute it to make a solution of a certain concentration; (2) The test solution and the reference solution of step (1) are subjected to gas chromatography-mass spectrometry detection, and the specific conditions are as follows: ① Gas chromatography: Chromatographic column: Polyethylene glycol column modified with nitroterephthalic acid Carrier gas: Helium Heating program: Initial temperature 50-70℃, heat to 210-230℃ at a rate of 15-25℃ / min, maintain for 1-5min, then run at 210-230℃ for 5-15min Flow rate: 0.8-1.2ml / min Split ratio: 10:1 Inlet temperature: 240-260℃ Injection volume: 0.5-2μl ②Mass spectrometry: Ion source: EI source Ion source temperature: 230°C Quadrupole temperature: 150°C Acquisition mode: Selected ion monitoring SIM The ion pairs are shown in the table below: (3) Calculation of content: The residual monomer content in the test sample was calculated by the peak area using the external standard method.

7. The detection method according to any one of claims 1 to 6, characterized in that: The method specifically comprises: (1) Solution preparation: Test solution: Take an appropriate amount of PHA polymer, dissolve it in dichloromethane and quantitatively dilute it to make a solution containing about 5 mg per 1 ml. Reference solution: Take appropriate amounts of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid, dissolve them in dichloromethane and quantitatively dilute them to make a mixed solution containing about 50 μg of each in 1 ml. (2) Chromatographic conditions: ①Gas chromatography: Column: Agilent DB-FFAP, 30m×0.25mm, 0.25μm Carrier gas: Helium Heating program: Initial temperature 60℃, heating to 220℃ at a rate of 20℃ / min, maintaining for 3min, then maintaining at 220℃ for 10min. Flow rate: 0.9-1.1ml / min Split ratio: 10:1 Inlet temperature: 245-255°C Injection volume: 1 μl ②Mass spectrometry: Ion source: EI source, Ion source temperature: 230°C, Quadrupole temperature: 150°C Acquisition mode: Selected ion monitoring SIM Solvent delay: 4 minutes The ion pairs are shown in the table below: (3) Calculation of content: The residual monomer content in the test sample was calculated by peak area using the external standard method.

8. Use of the detection method according to any one of claims 1 to 7 in detecting residual monomers in PHA polymers.

9. The use according to claim 8, characterized in that: The PHA polymer is used as a dermal filler for medical aesthetics.